BridgeMD
New treatment option for Staphylococcus Aureus Septicemia
Official title Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
ClinicalTrials.gov ID: NCT06637332
What this study is testing
What is Daptomycin for Injection?
Daptomycin for Injection is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for staphylococcus aureus septicemia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is an open label randomized controlled trial for patients with methicillin resistant S. aureus (MRSA) bloodstream infection which will directly compare the two most commonly used therapies, vancomycin and daptomycin.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- The participant must meet all inclusion and
You likely can't join if
- for the SNAP Platform (NCT05137119) and also the following inclusion and exclusion criteria: Inclusion Criteria:
- Methicillin-resistant S. aureus bacteremia Exclusion Criteria:
- Severe allergy or non-severe rash to vancomycin or daptomycin
- Suspected or confirmed MRSA pneumonia
- Known vancomycin minimum inhibitory concentration (MIC) greater than or equal to 2mg/L or daptomycin MIC greater than or equal to 1mg/L
The study team makes the final eligibility decision.
Where it's taking place
- Blacktown, New South Wales, Australia
- Concord, New South Wales, Australia
- Newcastle, New South Wales, Australia
- Westmead, New South Wales, Australia
- Herston, Queensland, Australia
- Bedford Park, South Australia, Australia
- Box Hill, Victoria, Australia
- Clayton, Victoria, Australia
- Parkville, Victoria, Australia
- Murdoch, Western Australia, Australia
- Perth, Western Australia, Australia
- Edmonton, Alberta, Canada
- Surrey, British Columbia, Canada
- St. John's, Newfoundland and Labrador, Canada
- Hamilton, Ontario, Canada
- Toronto, Ontario, Canada
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Blacktown, New South Wales, Australia; Concord, New South Wales, Australia; Newcastle, New South Wales, Australia; Westmead, New South Wales, Australia; Herston, Queensland, Australia; Bedford Park, South Australia, Australia and 11 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.